Market Pulse - Usa
US Q2 GDP grows more quickly than expected
America's economy grew more quickly than expected last quarter as companies ramped up investment and amid inventory accumulation.
American Airlines posts record quarterly revenue but slashes earnings outlook
American Airlines reported its highest-ever quarterly revenue for its second quarter on Thursday, at $14. 3bn, although that still fell short of its own expectations, as the airline also lowered its full-year earnings guidance.
US pre-open: Futures little changed ahead of data points, Q2 earnings
Dow Jones futures were little changed ahead of the bell on Thursday as market participants looked ahead to the release of some key data points and more corporate earnings.
US close: Stocks sharply lower following Q2's first big-name tech earnings
Wall Street stocks closed sharply lower on Wednesday after investors got their first taste of Q2 big tech earnings overnight and thumbed over a number of data points.
US open: Stocks lower following tech earnings, data
Wall Street stocks were firmly in the red early on Wednesday after investors got their first taste of Q2 big tech earnings overnight and thumbed over a number of data points.
US pre-open: Futures lower following first batch of Q2 tech earnings
Wall Street futures were pointing to losses ahead of the bell on Wednesday after investors got their first taste of Q2 big tech earnings overnight.
US close: Stocks lower as Q2 tech earnings come into focus
Wall Street stocks closed lower on Tuesday as market participants got their first taste of big-name tech earnings for Q2.
US open: Stocks higher ahead of tech earnings
Wall Street stocks were in the green early on Tuesday as market participants looked ahead to a handful of big-name earnings reports after the close.
US pre-open: Wall Street futures little changed ahead of tech earnings
Wall Street futures were little changed ahead of the bell on Tuesday as market participants looked ahead to a handful of big-name earnings reports.
US close: Stocks higher following Biden's election race exit
Major indices closed higher on Monday after Joe Biden dropped out of the US presidential race over the weekend.
US open: Major indices trade higher following Biden's exit from presidential race
Major indices were in the green early on Monday after Joe Biden dropped out of the US presidential race over the weekend.
US pre-open: Futures higher as Biden drops out of presidential race
Wall Street futures were in the green ahead of the bell on Monday after Joe Biden dropped out of the US presidential race over the weekend.
US open: Stocks lower following global IT outage
Wall Street stocks were in the red early on Friday following heavy losses recorded a day earlier.
US pre-open: Futures lower amid global IT crash
Wall Street futures were in the red ahead of the bell on Friday following big losses for the Dow in the previous session.
US close: Stocks lower as Nasdaq extends slide another session
Major indices were in the red at the close of trading on Thursday following a heavy tech selloff in the previous session that saw the Nasdaq Composite deliver its worst daily performance since December 2022.
US open: Stocks higher following Nasdaq's worst day since 2022
Major indices were in the green early on Thursday following a heavy tech selloff that saw the Nasdaq Composite deliver its worst daily performance since December 2022.
US initial jobless claims rise by 20,000
Americans lined up for unemployment benefits at an accelerated pace in the week ended 13 July, according to the Labor Department.
US pre-open: Futures mixed following Nasdaq's worst session since 2022
Wall Street futures were mixed ahead of the bell on Thursday following the Nasdaq's worst session since December 2022.
PensionBee announces expansion into US market
PensionBee Group announced its expansion into the United States, the world's largest defined contribution pension market, on Thursday.
Johnson & Johnson shares rise on earnings beat despite mixed outlook
Johnson & Johnson's stock was in the green on Wednesday, after the pharmaceutical giant reported second-quarter earnings and sales that surpassed analysts' expectations, largely driven by its innovative medicines segment.